186 related articles for article (PubMed ID: 31851466)
1. The relationship of neutrophil to lymphocyte ratio with testicular cancer.
Ilktac A; Dogan B; Ersoz C; Akcay M; Akbulut H
Int Braz J Urol; 2020; 46(1):101-107. PubMed ID: 31851466
[TBL] [Abstract][Full Text] [Related]
2. White blood cell counts and neutrophil to lymphocyte ratio in the diagnosis of testicular cancer: a simple secondary serum tumor marker.
Yuksel OH; Verit A; Sahin A; Urkmez A; Uruc F
Int Braz J Urol; 2016; 42(1):53-9. PubMed ID: 27136467
[TBL] [Abstract][Full Text] [Related]
3. Neutrophil-to-lymphocyte ratio as a predictor of preoperative tumor staging in testicular germ cell tumors.
Jankovich M; Jankovichova T; Ondrus D; Breza J
Bratisl Lek Listy; 2017; 118(9):510-512. PubMed ID: 29061055
[TBL] [Abstract][Full Text] [Related]
4. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
5. Leukocyte and platelet counts as prognostic values of testicular germ cell tumours.
Herraiz-Raya L; Moreillo-Vicente L; Martínez-Ruiz J; Agustí-Martínez A; Fernández-Anguita PJ; Esper-Rueda JA; Salce-Marte L; Armas-Álvarez A; Díaz de Mera-Sánchez Migallón I; Martínez-Alfaro C; Giménez-Bachs JM; Donate-Moreno MJ; Salinas-Sánchez AS
Actas Urol Esp (Engl Ed); 2019; 43(6):284-292. PubMed ID: 31085041
[TBL] [Abstract][Full Text] [Related]
6. Serum Levels of MicroRNA-371a-3p (M371 Test) as a New Biomarker of Testicular Germ Cell Tumors: Results of a Prospective Multicentric Study.
Dieckmann KP; Radtke A; Geczi L; Matthies C; Anheuser P; Eckardt U; Sommer J; Zengerling F; Trenti E; Pichler R; Belz H; Zastrow S; Winter A; Melchior S; Hammel J; Kranz J; Bolten M; Krege S; Haben B; Loidl W; Ruf CG; Heinzelbecker J; Heidenreich A; Cremers JF; Oing C; Hermanns T; Fankhauser CD; Gillessen S; Reichegger H; Cathomas R; Pichler M; Hentrich M; Eredics K; Lorch A; Wülfing C; Peine S; Wosniok W; Bokemeyer C; Belge G
J Clin Oncol; 2019 Jun; 37(16):1412-1423. PubMed ID: 30875280
[TBL] [Abstract][Full Text] [Related]
7. Preoperative Inflammation Markers and De Ritis Ratio in Predicting Clinical Presentation and Prognosis of Patients with Testicular Germ Cell Tumors.
Olcucu MT; Karamik K; Yilmaz K; Okuducu Y; Cakir S; Ates M
J Coll Physicians Surg Pak; 2020 Oct; 30(10):1041-1046. PubMed ID: 33143824
[TBL] [Abstract][Full Text] [Related]
8. Serum miR371 in testicular germ cell cancer before and after orchiectomy, assessed by digital-droplet PCR in a prospective study.
Myklebust MP; Thor A; Rosenlund B; Gjengstø P; Karlsdottir Á; Brydøy M; Bercea BS; Olsen C; Johnson I; Berg MI; Langberg CW; Andreassen KE; Kjellman A; Haugnes HS; Dahl O
Sci Rep; 2021 Aug; 11(1):15582. PubMed ID: 34341387
[TBL] [Abstract][Full Text] [Related]
9. May High Levels of Systemic Immune-Inflammation Index and Hematologic Inflammation Markers Suggest a Further Stage in Testicular Tumours?
Imamoglu GI; Eren T; Baylan B; Karacın C
Urol Int; 2019; 103(3):303-310. PubMed ID: 31466076
[TBL] [Abstract][Full Text] [Related]
10. What Is the Significance of Rete Testis Invasion by Malign Germ Cell Tumor and Does Hilum Predict Metastasis?
Ediz C; Ihvan A
Urol Int; 2019; 103(1):49-54. PubMed ID: 31203276
[TBL] [Abstract][Full Text] [Related]
11. Serum lactate dehydrogenase isoenzyme 1 as a marker of testicular germ cell tumor.
von Eyben FE; Blaabjerg O; Petersen PH; Hørder M; Nielsen HV; Kruse-Andersen S; Parlev E
J Urol; 1988 Nov; 140(5):986-90. PubMed ID: 2845154
[TBL] [Abstract][Full Text] [Related]
12. CA19-9: a possible serum marker for embryonal carcinoma.
Tsuruta T; Ogawa A; Ishii K; Ikado S
Urol Int; 1997; 58(1):20-4. PubMed ID: 9058515
[TBL] [Abstract][Full Text] [Related]
13. Hyperglycosylated human chorionic gonadotropin in serum of testicular cancer patients.
Lempiäinen A; Hotakainen K; Blomqvist C; Alfthan H; Stenman UH
Clin Chem; 2012 Jul; 58(7):1123-9. PubMed ID: 22529110
[TBL] [Abstract][Full Text] [Related]
14. [Clinical presentation of testicular germinal cancer].
Fernández Gómez JM; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; Escaf Barmadah S; García Rodríguez J; Pérez García FJ; Rodríguez Faba O; Jalón Monzón A
Arch Esp Urol; 2002 Oct; 55(8):915-22. PubMed ID: 12455282
[TBL] [Abstract][Full Text] [Related]
15. Appendix 9: Testicular seminoma and non-seminoma: eUpdate published online 29 June 2017 (www.esmo.org/Guidelines/Genitourinary-Cancers).
Oldenburg J; Horwich A;
Ann Oncol; 2017 Jul; 28(suppl_4):iv165-iv166. PubMed ID: 28881930
[No Abstract] [Full Text] [Related]
16. Real-World Application of Pre-Orchiectomy miR-371a-3p Test in Testicular Germ Cell Tumor Management.
Badia RR; Abe D; Wong D; Singla N; Savelyeva A; Chertack N; Woldu SL; Lotan Y; Mauck R; Ouyang D; Meng X; Lewis CM; Majmudar K; Jia L; Kapur P; Xu L; Frazier AL; Margulis V; Strand DW; Coleman N; Murray MJ; Amatruda JF; Lafin JT; Bagrodia A
J Urol; 2021 Jan; 205(1):137-144. PubMed ID: 32856980
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of miRNAs in the seminal plasma and serum of testicular cancer patients.
Pelloni M; Coltrinari G; Paoli D; Pallotti F; Lombardo F; Lenzi A; Gandini L
Endocrine; 2017 Sep; 57(3):518-527. PubMed ID: 27796811
[TBL] [Abstract][Full Text] [Related]
18. Associations of preorchiectomy hormone levels to testicular germ cell tumor pathology, clinical stage, and size.
Pineault KG; Cheaib JG; Herati AS; Pierorazio PM
Asian J Androl; 2021; 23(2):224-226. PubMed ID: 32567579
[No Abstract] [Full Text] [Related]
19. Reliability of Serum Tumor Marker Measurement to Diagnose Recurrence in Patients with Clinical Stage I Nonseminomatous Germ Cell Tumors Undergoing Active Surveillance: A Systematic Review.
Chakiryan NH; Dahmen A; Cucchiara V; Briganti A; Montorsi F; Salonia A; Spiess PE; Necchi A
J Urol; 2021 Jun; 205(6):1569-1576. PubMed ID: 33617328
[TBL] [Abstract][Full Text] [Related]
20. Pure Testicular Seminoma with Non-Pathologic Elevation of Alpha Fetoprotein: A Case Series.
Dieckmann KP; Anheuser P; Simonsen H; Höflmayer D
Urol Int; 2017; 99(3):353-357. PubMed ID: 28668957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]